Deals Or No Deals, J.P. Morgan Sets The Tone For 2022
Collaborations, Not M&A, Dominate
No big buyouts were revealed during the annual J.P. Morgan Healthcare Conference for a third year in a row. Big pharma firms are in acquisition mode, but execs stress desire for easy integrations and scientific alliances.
